CAS NO: | 915020-55-2 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | BGT226 (NVP-BGT226) is aPI3K(withIC50s of 4 nM, 63 nM and 38 nM forPI3Kα,PI3KβandPI3Kγ)/mTORdual inhibitor which displays potent growth-inhibitory activity against human head and neckcancercells[1][2]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | BGT226 shows significant growth inhibition or signal blockage profiles compared with LY294002 and Rapamycin. BGT226 (10-10000 nM) inhibits FaDu and OECM1 cells growth with IC50s of 23.1±7.4 and 12.5±5.1 nM, respectively[2]. Cell Viability Assay[2]
Western Blot Analysis[2]
| ||||||||||||||||
体内研究 (In Vivo) | BGT226 (2.5 and 5 mg/kg; oral administration for 21 days in male athymic mice) causes 34.7% and 76.1% reduction of the tumor growth on day 21 compared with control[2].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 534.53 | ||||||||||||||||
Formula | C28H25F3N6O2 | ||||||||||||||||
CAS 号 | 915020-55-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |